» Articles » PMID: 14090569

[A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES: RUBIDOMYCIN]

Overview
Specialty Science
Date 1963 Sep 9
PMID 14090569
Citations 20
Authors
Affiliations
Soon will be listed here.
Citing Articles

Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment.

Fabiani I, Chianca M, Cipolla C, Cardinale D Nat Rev Cardiol. 2025; .

PMID: 39875555 DOI: 10.1038/s41569-025-01126-1.


Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations.

Machado C, DE Pinho Pessoa F, da Silva E, da Costa Pantoja L, Ribeiro R, de Moraes Filho M Pharmaceutics. 2021; 13(10).

PMID: 34683897 PMC: 8540545. DOI: 10.3390/pharmaceutics13101604.


Echocardiographic evaluation of cardiac function after cancer chemotherapy.

Negishi T, Negishi K J Echocardiogr. 2017; 16(1):20-27.

PMID: 28698984 DOI: 10.1007/s12574-017-0344-6.


Oncocardiology-Past, Present, and Future: A Review.

Yeh E, Chang H JAMA Cardiol. 2016; 1(9):1066-1072.

PMID: 27541948 PMC: 5788289. DOI: 10.1001/jamacardio.2016.2132.


Inching toward cure of acute myeloid leukemia: a summary of the progress made in the last 50 years.

Wiernik P Med Oncol. 2014; 31(8):136.

PMID: 25048723 DOI: 10.1007/s12032-014-0136-z.